ENXTPA:ALCJMedical Equipment
Crossject Société Anonyme (ENXTPA:ALCJ) Loss Narrows Challenging Bearish Profitability Narratives
Crossject Société Anonyme (ENXTPA:ALCJ) reported first half FY 2025 revenue of €1.54 million, with a basic EPS loss of €0.10 and net income loss of €4.87 million, at a share price of €1.98. The company has seen revenue remain within a relatively tight band over recent periods, from €1.58 million in the first half of 2024 to €2.53 million in the second half of 2024. Over the same halves, basic EPS moved from a loss of €0.16 to a loss of €0.13, and investors now have to weigh this earnings...